Entero Therapeutics

Yahoo Finance • 27 days ago

Which stocks are experiencing notable movement on Friday?

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE COMMENT GCTK [ht... Full story

Yahoo Finance • 2 months ago

Entero Therapeutics stock falls after announcing reverse stock split

Investing.com -- Entero Therapeutics Inc (NASDAQ:ENTO) stock fell 5.7% after the clinical-stage biopharmaceutical company announced plans for a 1-for-3 reverse stock split to regain Nasdaq compliance. The company, which specializes in dev... Full story

Yahoo Finance • 2 months ago

Which stocks are experiencing notable movement on Monday?

Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] GAINERS TICKER CHANGE COMMENT EQ [https://www.chartmill.com/stock/quote/EQ/profile] 77.82% Positive ma... Full story

Yahoo Finance • 2 months ago

Let's have a look at the top gainers and losers in the middle of the day of today's session.

Here are the top movers in Monday's session, showcasing the stocks with significant price changes. [topmovers] GAINERS TICKER CHANGE COMMENT EQ [https://www.chartmill.com/stock/quote/EQ/profile] 87.56% With a 87.56% surge... Full story

Yahoo Finance • 2 months ago

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Wang & Lee Group Inc. 319,475,864 0.069 0.0559 0.0592 +0.0134 Entero The... Full story

Yahoo Finance • 2 months ago

Monday's session: gap up and gap down stocks

The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT ENTO [https://www.chartmill.com/stock/quote/ENTO/p... Full story

Yahoo Finance • 2 months ago

Monday's pre-market session: top gainers and losers

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT E... Full story

Yahoo Finance • 2 months ago

Entero Therapeutics raises $3 million through warrant offering

BOCA RATON - Entero Therapeutics, Inc. (NASDAQ:ENTO), currently valued at $1.74 million and showing a -14% return over the past week according to InvestingPro, has secured approximately $3 million through private placement agreements with... Full story

Yahoo Finance • 3 months ago

Entero Therapeutics regains Nasdaq compliance after annual meeting

Entero Therapeutics, Inc. (NASDAQ:ENTO), currently trading at $0.53 with a market capitalization of $2.57 million, announced Tuesday that it has regained compliance with Nasdaq Listing Rule 5620(a) following the successful holding of its a... Full story

Yahoo Finance • 3 months ago

Entero Therapeutics receives Nasdaq extension to regain equity compliance

Entero Therapeutics, Inc. (NASDAQ:ENTO) announced Monday that it has received an extension from the Nasdaq Stock Market to regain compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Mark... Full story

Yahoo Finance • 8 months ago

Entero Therapeutics Appoints Richard Paolone as CEO

BOCA RATON, Fla., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for... Full story

Yahoo Finance • 8 months ago

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members

BOCA RATON, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for... Full story